128 related articles for article (PubMed ID: 26314440)
1. [PET/CT Image Values in Clinical Staging of the Patients with Non-Hodgkin's Lymphoma].
Tang HJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1030-3. PubMed ID: 26314440
[TBL] [Abstract][Full Text] [Related]
2. The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
Akkas BE; Vural GU
Nucl Med Commun; 2013 Jan; 34(1):50-6. PubMed ID: 23111376
[TBL] [Abstract][Full Text] [Related]
3. Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma.
Cheng G; Servaes S; Zhuang H
Leuk Lymphoma; 2013 Apr; 54(4):737-42. PubMed ID: 22957898
[TBL] [Abstract][Full Text] [Related]
4. [Non-Hodgkin's lymphoma staging: a prospective study of the value of positron emission tomography/computed tomography (PET/CT) versus PET and CT].
Rodríguez-Vigil Junco B; Gómez León N; Pinilla Fernández I; del Campo L; Hernández Maraver D; Coya J
Med Clin (Barc); 2011 Oct; 137(9):383-9. PubMed ID: 21703647
[TBL] [Abstract][Full Text] [Related]
5. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
6. The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma.
Fujiwara H; Maeda Y; Nawa Y; Yamakura M; Ennishi D; Miyazaki Y; Shinagawa K; Hara M; Matsue K; Tanimoto M
Eur J Haematol; 2011 Aug; 87(2):123-9. PubMed ID: 21557776
[TBL] [Abstract][Full Text] [Related]
7. Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CT.
Papajik T; Myslivecek M; Skopalova M; Malan A; Buriankova E; Koza V; Hnatkova M; Trneny M; Sedova Z; Kubova Z; Koranda P; Flodr P; Jarkovsky J; Dusek L; Indrak K
Neoplasma; 2011; 58(4):291-7. PubMed ID: 21524147
[TBL] [Abstract][Full Text] [Related]
8. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography/computed tomography in the management of Hodgkin's disease and non-Hodgkin's lymphoma.
Rodríguez-Vigil B; Gómez-León N; Pinilla I; Hernández-Maraver D; Coya J; Martín-Curto L
Curr Probl Diagn Radiol; 2006; 35(4):151-63. PubMed ID: 16814002
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
[TBL] [Abstract][Full Text] [Related]
11. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
Mosavi F; Wassberg C; Selling J; Molin D; Ahlström H
Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992
[TBL] [Abstract][Full Text] [Related]
12. PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas.
Sattar T; Griffeth LK; Latifi HR; Glass J; Munker R; Lilien DL
J La State Med Soc; 2006; 158(4):193-201. PubMed ID: 17022364
[TBL] [Abstract][Full Text] [Related]
13. Multimodality imaging of direct ureteric involvement in non-Hodgkin's lymphoma using PET/CT, CT urography and antegrade CT pyelography.
Ghersin E; Keidar Z; Eldad DJ; Bar-Shalom R; Fischer D; Halachmi S
Br J Radiol; 2007 Nov; 80(959):e283-6. PubMed ID: 17989329
[TBL] [Abstract][Full Text] [Related]
14. [Application of 18F-FDG PET/CT images in the newly diagnosed extranodal NK/T cell lymphoma].
Hu YJ; Liang JH; Fan L; Wang L; Ding CY; Li TN; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):127-31. PubMed ID: 25687059
[TBL] [Abstract][Full Text] [Related]
15. Giant cardiac tumour thrombus on staging contrast enhanced ¹⁸F-FDG PET/CT in a case of non-Hodgkin's lymphoma.
Jeph S; Thakur K; Shamim SA; Verma K; Aggarwal B; Aggarwal A
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):328-9. PubMed ID: 24618093
[No Abstract] [Full Text] [Related]
16. Imaging of extranodal lymphoma with PET/CT.
Ilica AT; Kocacelebi K; Savas R; Ayan A
Clin Nucl Med; 2011 Oct; 36(10):e127-38. PubMed ID: 21892025
[TBL] [Abstract][Full Text] [Related]
17. [Non-hodgkin's lymphomas of extranodal localization. Strategies for imaging diagnosis].
Scutellari PN; Borgatti L; Spanedda R
Radiol Med; 2000 Oct; 100(4):262-72. PubMed ID: 11155454
[TBL] [Abstract][Full Text] [Related]
18. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P
J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
[TBL] [Abstract][Full Text] [Related]
20. Comparison of CT, PET, and PET/CT for staging of patients with indolent non-hodgkin's lymphoma: statistical errors in Fueger et al. (2009).
White LR
Mol Imaging Biol; 2012 Aug; 14(4):397-8; author reply 399-401. PubMed ID: 21814856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
